Irreversible electroporation combined with checkpoint blockade stimulates antitumor immune response in a hepatocellular carcinoma mouse model

doi:10.4251/wjgo.v17.i9.110166

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 9

This Article

(47)

(44)

(0)

(642)

(2)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Gastrointest Oncol. Sep 15, 2025; 17(9): 110166
Published online Sep 15, 2025. doi: 10.4251/wjgo.v17.i9.110166

Full Size Figure Download Figure

Figure 4 The irreversible electroporation combined programmed cell death protein 1 antibody markedly enhanced tumor regression. Variations in tumor size expressed as means ± SED. ^bP < 0.01. ^cP < 0.001. IRE: Irreversible electroporation; PD-1: Programmed cell death protein 1.

Citation: Xing YL, Li HM, Pang XM, Zhang Y, Yang T, Li YH, Liu DC, Ma YY, Niu LZ. Irreversible electroporation combined with checkpoint blockade stimulates antitumor immune response in a hepatocellular carcinoma mouse model. World J Gastrointest Oncol 2025; 17(9): 110166
URL: https://www.wjgnet.com/1948-5204/full/v17/i9/110166.htm
DOI: https://dx.doi.org/10.4251/wjgo.v17.i9.110166

Xing YL, Li HM, Pang XM, Zhang Y, Yang T, Li YH, Liu DC, Ma YY, Niu LZ. Irreversible electroporation combined with checkpoint blockade stimulates antitumor immune response in a hepatocellular carcinoma mouse model. World J Gastrointest Oncol 2025; 17(9): 110166 [PMID: 40977659 DOI: 10.4251/wjgo.v17.i9.110166]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.